Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-26
2009-10-06
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S297000, C544S242000, C544S217000, C544S323000
Reexamination Certificate
active
07598260
ABSTRACT:
This invention relates to pyrimidine derivatives of general formula Iin which R1, R2, X, A and B have the meanings that are contained in the description, as inhibitors of the cyclin-dependent kinases, their production as well as their use as medications for treating various diseases.
REFERENCES:
patent: 5958935 (1999-09-01), Davis et al.
patent: 7235561 (2007-06-01), Brumby et al.
patent: 7291624 (2007-11-01), Brumby et al.
Curd et al.,1946, CAS:40:25718.
Curd, F.H.S., et al., “Synthetic Antimalarials. Part VII. 2-Arylamino-4-dialkylaminoalkylamino-pyrimidines. Variation of Substituents in the 5- and the 6- position.” Imperial Chemical Industries, Limited, Received Jul. 31, 1945. pp. 378-385.
Brumby Thomas
Huwe Christoph
Jautelat Rolf
Lücking Ulrich
Prien Olaf
Bayer Schering Pharma Aktiengesellschaft
Millen White Zelano & Branigan P.C.
Shiao Rei-tsang
LandOfFree
CDK-inhibitory pyrimidines, their production and use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CDK-inhibitory pyrimidines, their production and use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CDK-inhibitory pyrimidines, their production and use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070846